Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AEterna Zentaris Inc. (USA) - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AEZS
Nasdaq
8731
https://www.zentaris.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AEterna Zentaris Inc. (USA)
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
- Mar 28th, 2024 11:55 am
Aeterna Zentaris (AEZS) Reports Q4 Loss, Tops Revenue Estimates
- Mar 27th, 2024 1:25 pm
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
- Mar 27th, 2024 12:05 pm
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
- Mar 12th, 2024 6:10 pm
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
- Feb 26th, 2024 12:30 pm
Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro
- Feb 15th, 2024 10:50 pm
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company
- Dec 14th, 2023 12:50 pm
Aeterna Zentaris Reports Third Quarter 2023 Financial Results
- Nov 9th, 2023 1:00 pm
Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO Conference
- Oct 11th, 2023 12:00 pm
Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Sep 5th, 2023 12:00 pm
Aeterna Zentaris (AEZS) Reports Q2 Loss, Tops Revenue Estimates
- Aug 9th, 2023 1:40 pm
Aeterna Zentaris Reports Second Quarter 2023 Financial Results
- Aug 9th, 2023 12:05 pm
Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate Update
- Jul 13th, 2023 11:30 am
Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series
- Jul 5th, 2023 12:45 pm
Aeterna Zentaris Announces Results of Virtual 2023 Meeting of Shareholders
- Jun 14th, 2023 8:05 pm
Aeterna Zentaris Announces Virtual 2023 Meeting of Shareholders
- May 15th, 2023 8:05 pm
Aeterna Zentaris Reports First Quarter 2023 Financial Results
- May 9th, 2023 9:00 pm
Scroll